KPTI logo

Karyopharm Therapeutics (KPTI) Accounts Payable

Annual Accounts Payable

$5.11 M
+$1.98 M+63.53%

December 31, 2024

Summary

Performance

1-Year Change

+63.53%

3-Year Change

+218.59%

5-Year Change

+418.48%

15-Year Change

-9.85%

KPTI Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

55.69%
KPTI annual accounts payable is higher than 55.69% of companies in Healthcare sector

High & Low

All-time High

$6.29 M
KPTI annual accounts payable is currently -18.78% below its historical high of $6.29 million

3-Year Low

$1.60 M
KPTI annual accounts payable is currently +218.59% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
KPTI previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
KPTI next annual earnings announcement has not yet been scheduled

OtherKPTIbalance sheetmetrics:

Annual Accounts Receivable

$30.77 M
KPTI annual accounts receivable is $30.77 million

Annual Total Liabilities

$350.44 M
KPTI annual total liabilities is $350.44 million

Annual Total Assets

$164.42 M
KPTI annual total assets is $164.42 million

Annual Current Assets

$156.49 M
KPTI annual total current assets is $156.49 million

Quarterly Accounts Payable

N/A

December 31, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

KPTI Quarterly Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$9.04 M
KPTI quarterly accounts payable is currently at an all-time high

3-Year Low

$813.00 K
KPTI quarterly accounts payable is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
KPTI previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

N/A
KPTI next earnings announcement has not yet been scheduled

OtherKPTIbalance sheetmetrics:

Quarterly Accounts Receivable

-
KPTI quarterly accounts receivable value is unknown

Quarterly Total Liabilities

$350.44 M
KPTI quarterly total liabilities is $350.44 million

Quarterly Total Assets

$164.42 M
KPTI quarterly total assets is $164.42 million

Quarterly Current Assets

-
KPTI quarterly total current assets value is unknown

Accounts Payable Formula

Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers

KPTI Accounts Payable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+63.5%-
3 y3 years+218.6%-
5 y5 years+418.5%-

KPTI Accounts Payable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+218.6%
5 y5-yearat high+418.5%
alltimeall time-18.8%+418.5%

Karyopharm Therapeutics Accounts Payable History

DateAnnualQuarterly
Dec 2024
$5.11 M(+63.5%)
-
Sep 2024
-
$5.78 M(+106.8%)
Jun 2024
-
$2.80 M(-44.4%)
Mar 2024
-
$5.03 M(+61.0%)
Dec 2023
$3.12 M(+12.6%)
$3.12 M(+231.2%)
Sep 2023
-
$943.00 K(-58.8%)
Jun 2023
-
$2.29 M(-74.7%)
Mar 2023
-
$9.04 M(+226.2%)
Dec 2022
$2.77 M(+73.0%)
$2.77 M(+241.1%)
Sep 2022
-
$813.00 K(-52.0%)
Jun 2022
-
$1.69 M(-50.8%)
Mar 2022
-
$3.44 M(+114.6%)
Dec 2021
$1.60 M(-64.0%)
$1.60 M(+82.0%)
Sep 2021
-
$881.00 K(-61.8%)
Jun 2021
-
$2.31 M(-24.0%)
Mar 2021
-
$3.04 M(-31.7%)
Dec 2020
$4.45 M(+351.8%)
$4.45 M(+83.7%)
Sep 2020
-
$2.42 M(+28.3%)
Jun 2020
-
$1.89 M(+11.5%)
Mar 2020
-
$1.69 M(+72.0%)
Dec 2019
$985.00 K(-77.3%)
$985.00 K(-67.9%)
Sep 2019
-
$3.07 M(+175.7%)
Jun 2019
-
$1.11 M(-50.9%)
Mar 2019
-
$2.27 M(-47.7%)
DateAnnualQuarterly
Dec 2018
$4.33 M(-23.5%)
$4.33 M(+93.6%)
Sep 2018
-
$2.24 M(-41.0%)
Jun 2018
-
$3.79 M(-23.3%)
Mar 2018
-
$4.95 M(-12.6%)
Dec 2017
$5.67 M(+19.2%)
$5.67 M(+199.7%)
Sep 2017
-
$1.89 M(-41.8%)
Jun 2017
-
$3.25 M(-23.5%)
Mar 2017
-
$4.25 M(-10.7%)
Dec 2016
$4.75 M(+24.8%)
$4.75 M(+116.6%)
Sep 2016
-
$2.19 M(-46.0%)
Jun 2016
-
$4.06 M(-1.1%)
Mar 2016
-
$4.11 M(+7.9%)
Dec 2015
$3.81 M(-39.4%)
$3.81 M(-16.6%)
Sep 2015
-
$4.57 M(+2.2%)
Jun 2015
-
$4.47 M(-35.8%)
Mar 2015
-
$6.96 M(+10.6%)
Dec 2014
$6.29 M(+261.4%)
$6.29 M(+199.1%)
Sep 2014
-
$2.10 M(-39.2%)
Jun 2014
-
$3.46 M(+5.6%)
Mar 2014
-
$3.27 M(+88.1%)
Dec 2013
$1.74 M(+61.7%)
$1.74 M(-0.5%)
Sep 2013
-
$1.75 M(+1.2%)
Jun 2013
-
$1.73 M(+60.6%)
Dec 2012
$1.08 M(-5.8%)
$1.08 M
Dec 2011
$1.14 M
-

FAQ

  • What is Karyopharm Therapeutics annual accounts payable?
  • What is the all time high annual accounts payable for Karyopharm Therapeutics?
  • What is Karyopharm Therapeutics annual accounts payable year-on-year change?
  • What is the all time high quarterly accounts payable for Karyopharm Therapeutics?

What is Karyopharm Therapeutics annual accounts payable?

The current annual accounts payable of KPTI is $5.11 M

What is the all time high annual accounts payable for Karyopharm Therapeutics?

Karyopharm Therapeutics all-time high annual accounts payable is $6.29 M

What is Karyopharm Therapeutics annual accounts payable year-on-year change?

Over the past year, KPTI annual accounts payable has changed by +$1.98 M (+63.53%)

What is the all time high quarterly accounts payable for Karyopharm Therapeutics?

Karyopharm Therapeutics all-time high quarterly accounts payable is $9.04 M